Sequenom Runs Nearly 41K MaterniT21 Tests; Reports Mixed Progress on Reimbursement | GenomeWeb

This story has been corrected to note that Quest has not yet stopped offering Natera's Panorama test.

NEW YORK (GenomeWeb) – Sequenom ran 40,800 of its MaterniT21 Plus tests in the second quarter of 2014, up 7 percent from the second quarter of 2013, the company reported this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.